ES527249A0 - Un procedimiento para la preparacion de 4"-epi-9-desoxo-9a-metil-9a-aza-9a-homoeritromicina a - Google Patents

Un procedimiento para la preparacion de 4"-epi-9-desoxo-9a-metil-9a-aza-9a-homoeritromicina a

Info

Publication number
ES527249A0
ES527249A0 ES527249A ES527249A ES527249A0 ES 527249 A0 ES527249 A0 ES 527249A0 ES 527249 A ES527249 A ES 527249A ES 527249 A ES527249 A ES 527249A ES 527249 A0 ES527249 A0 ES 527249A0
Authority
ES
Spain
Prior art keywords
epi
aza
methyl
desoxo
homoerythromycin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES527249A
Other languages
English (en)
Spanish (es)
Other versions
ES8600327A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Inc
Original Assignee
Pfizer Corp Belgium
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Inc filed Critical Pfizer Corp Belgium
Publication of ES8600327A1 publication Critical patent/ES8600327A1/es
Publication of ES527249A0 publication Critical patent/ES527249A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cosmetics (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
ES527249A 1982-11-15 1983-11-14 Un procedimiento para la preparacion de 4"-epi-9-desoxo-9a-metil-9a-aza-9a-homoeritromicina a Granted ES527249A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US44197982A 1982-11-15 1982-11-15

Publications (2)

Publication Number Publication Date
ES8600327A1 ES8600327A1 (es) 1985-10-01
ES527249A0 true ES527249A0 (es) 1985-10-01

Family

ID=23755068

Family Applications (2)

Application Number Title Priority Date Filing Date
ES527249A Granted ES527249A0 (es) 1982-11-15 1983-11-14 Un procedimiento para la preparacion de 4"-epi-9-desoxo-9a-metil-9a-aza-9a-homoeritromicina a
ES543638A Expired ES8604257A1 (es) 1982-11-15 1985-05-29 Un procedimiento para la preparacion de 4-epi-9-desoxo-9a- metil-9a-aza-9a-homoeritromicina a

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES543638A Expired ES8604257A1 (es) 1982-11-15 1985-05-29 Un procedimiento para la preparacion de 4-epi-9-desoxo-9a- metil-9a-aza-9a-homoeritromicina a

Country Status (26)

Country Link
EP (1) EP0109253B1 (en, 2012)
JP (1) JPS59104398A (en, 2012)
KR (1) KR850000968B1 (en, 2012)
AT (1) ATE30237T1 (en, 2012)
AU (1) AU544790B2 (en, 2012)
CA (1) CA1239639A (en, 2012)
CS (1) CS241069B2 (en, 2012)
DD (1) DD216017A5 (en, 2012)
DE (1) DE3374065D1 (en, 2012)
DK (1) DK159322C (en, 2012)
EG (1) EG16641A (en, 2012)
ES (2) ES527249A0 (en, 2012)
FI (1) FI72980C (en, 2012)
GR (1) GR79425B (en, 2012)
GT (1) GT198304062A (en, 2012)
HU (1) HU193886B (en, 2012)
IE (1) IE56234B1 (en, 2012)
IL (1) IL70228A (en, 2012)
NO (1) NO160262C (en, 2012)
NZ (1) NZ206259A (en, 2012)
PH (2) PH19293A (en, 2012)
PL (2) PL143281B1 (en, 2012)
PT (1) PT77645B (en, 2012)
SU (1) SU1272996A3 (en, 2012)
YU (2) YU43198B (en, 2012)
ZA (1) ZA838460B (en, 2012)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0136831B1 (en) * 1983-09-06 1988-11-09 Pfizer Inc. Azahomoerythromycin b derivatives and intermediates thereof
US4465674A (en) * 1983-09-06 1984-08-14 Pfizer Inc. Azahomoerythromycin D derivative and intermediates therefor
RO107257B1 (ro) * 1987-07-09 1993-10-30 Pfizer Procedeu de obtinere a unui dihidrat de azitromicina, cristalin
WO1989002271A1 (en) * 1987-09-10 1989-03-23 Pfizer Azithromycin and derivatives as antiprotozoal agents
JP2751385B2 (ja) * 1988-05-19 1998-05-18 大正製薬株式会社 エリスロマイシンａオキシム及びその塩の製造方法
US5075289A (en) * 1988-06-07 1991-12-24 Abbott Laboratories 9-r-azacyclic erythromycin antibiotics
SI8911498B (sl) * 1989-07-26 1998-10-31 Pliva Postopek za pripravo derivatov tilozina
US5912331A (en) * 1991-03-15 1999-06-15 Merck & Co., Inc. Process for the preparation of 9-deoxo-9(Z)-hydroxyiminoerythromycin A
US5985844A (en) * 1992-03-26 1999-11-16 Merck & Co., Inc. Homoerythromycin A derivatives modified at the 4"-and 8A-positions
CA2064634C (en) * 1991-04-04 1998-08-04 James V. Heck 9-deoxo-8a-aza-8a-homoerythromycin a derivatives modified at the 4"- and8a-positions
CA2064985A1 (en) * 1991-04-05 1992-10-06 Robert R. Wilkening 8a-aza-8a-homoertyhromycin cyclic lactams
CA2065222A1 (en) * 1991-04-09 1992-10-10 Robert R. Wilkening Process for the preparation of 8a-aza-8a-homoerythromycin cyclic iminoethers
US5189159A (en) * 1992-04-02 1993-02-23 Merck & Co., Inc. 8a-AZA-8a-homoerythromycin cyclic iminoethers
CA2065674A1 (en) * 1991-04-10 1992-10-11 Robert R. Wilkening 8a-aza-8a-homoerythromycin cyclic iminoethers
CA2065218A1 (en) * 1991-04-11 1992-10-12 Robert R. Wilkening Process for the preparation of 9-deoxo-8a-aza-8a-homoerythromycin a and its 8a-alkyl derivatives
EP0515141A1 (en) * 1991-05-20 1992-11-25 Merck & Co. Inc. Novel process for the preparation of 8A-aza-8A-homoerythromycin cyclic lactams
EP0549040A1 (en) * 1991-12-20 1993-06-30 Merck & Co. Inc. Methods of making 4" derivatives of 9-deoxo-8a-aza-8a-alkyl-8a-homoerythromycin A
US5215980A (en) * 1992-01-17 1993-06-01 Merck & Co., Inc. 10-AZA-9-deoxo-11-deoxy-erythromycin A and derivatives thereof
US5210235A (en) * 1992-08-26 1993-05-11 Merck & Co., Inc. Methods of elaborating erythromycin fragments into amine-containing fragments of azalide antibiotics
HRP930014A2 (en) * 1993-01-08 1994-08-31 Pliva Pharm & Chem Works 9-deoxo-9a-aza-11-deoxy-9a-homoeritromycin a 9a, 11-cyclic carbamates
US5332807A (en) * 1993-04-14 1994-07-26 Merck & Co., Inc. Process of producing 8A- and 9A-azalide antibiotics
WO1995030422A1 (en) * 1994-05-06 1995-11-16 Pfizer Inc. Controlled-release dosage forms of azithromycin
PT840606E (pt) * 1995-06-29 2000-11-30 Texas Biotechnology Corp Moleculas pequenas di-e trivalentes inibidoras de selectina
HRP960497B1 (en) * 1996-10-28 2003-08-31 Pliva Pharm & Chem Works 9-n-ethenyl derivatives of 9(s)-erythromycylamine
PT102006B (pt) * 1997-05-19 2000-06-30 Hovione Sociedade Quimica S A Novo processo de preparacao de azitromicina
TW546302B (en) * 1998-05-08 2003-08-11 Biochemie Sa Improvements in macrolide production
US6043227A (en) * 1998-08-19 2000-03-28 Pfizer Inc. C11 carbamates of macrolide antibacterials
EP1437360A3 (en) * 1998-08-19 2005-04-06 Pfizer Products Inc. C11 Carbamates of macrolide antibacterials
US6764996B1 (en) 1999-08-24 2004-07-20 Abbott Laboratories 9a-azalides with antibacterial activity
AU6748500A (en) * 1999-08-24 2001-03-19 Abbott Laboratories 9a-azalides with antibacterial activity
WO2001049697A1 (en) * 2000-01-04 2001-07-12 Teva Pharmaceutical Industries Ltd. Preparation method of azithromycin dihydrate
JP2004506664A (ja) 2000-08-23 2004-03-04 ウォックハート・リミテッド 無水アジトロマイシンの製造法
US6852262B2 (en) 2002-05-09 2005-02-08 The Gillette Company Insert molding razor cartridges
HRP20020991A2 (en) * 2002-12-12 2005-02-28 Pliva-Istra�iva�ki institut d.o.o. N"-Substituted 9a-N-(N'-carbamoyl-Gamma-aminopropyl), 9a-N-(N'? -thiocarbamoyl-Gamma-aminopropyl), 9a-N-(N'-((Beta-cyanoethyl)-N'-carbamoyl-Gamma? -aminopropyl) and 9a-N-(N'-(Beta-cyanoethyl)-N'-thiocarbamoyl-Gamma? -aminopropyl) derivatives of 9-de
CN1889932A (zh) 2003-12-04 2007-01-03 辉瑞产品公司 制备药用多颗粒的方法
CA2549225A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Spray-congeal process using an extruder for preparing multiparticulate crystalline drug compositions containing preferably a poloxamer and a glyceride
WO2005053652A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
BRPI0416534A (pt) 2003-12-04 2007-01-09 Pfizer Prod Inc composições multiparticuladas com estabilidade melhorada
US6984403B2 (en) 2003-12-04 2006-01-10 Pfizer Inc. Azithromycin dosage forms with reduced side effects
RU2256665C1 (ru) * 2004-01-29 2005-07-20 Открытое акционерное общество Акционерное Курганское общество медицинских препаратов и изделий "Синтез" Способ получения оксима эритромицина

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU43116B (en) * 1979-04-02 1989-04-30 Pliva Pharm & Chem Works Process for preparing 11-aza-4-o-cladinosyl-6-o-desosaminyl-15-ethyl-7,13,14-trihydroxy-3,5,7,9,12,14-hexamethyl-oxacyclopentadecane-2-one(11-aza-10-deox
JPS5788193A (en) * 1980-11-21 1982-06-01 Pliva Pharm & Chem Works 11-aza-10-deoxo-10-dihydroerythromycin a, derivatives and manufacture
YU43006B (en) * 1981-03-06 1989-02-28 Pliva Pharm & Chem Works Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof
US4382085A (en) * 1982-03-01 1983-05-03 Pfizer Inc. 4"-Epi erythromycin A and derivatives thereof as useful antibacterial agents

Also Published As

Publication number Publication date
PT77645A (en) 1983-12-01
FI72980B (fi) 1987-04-30
ES8604257A1 (es) 1986-01-16
FI834163A0 (fi) 1983-11-14
DD216017A5 (de) 1984-11-28
DE3374065D1 (en) 1987-11-19
IL70228A (en) 1987-03-31
DK159322C (da) 1991-02-25
ZA838460B (en) 1985-06-26
YU43198B (en) 1989-04-30
NO160262B (no) 1988-12-19
EG16641A (en) 1990-08-30
GT198304062A (es) 1985-05-04
ATE30237T1 (de) 1987-10-15
KR850000968B1 (ko) 1985-07-02
KR840006673A (ko) 1984-12-01
HU193886B (en) 1987-12-28
DK159322B (da) 1990-10-01
GR79425B (en, 2012) 1984-10-22
DK518683D0 (da) 1983-11-14
ES8600327A1 (es) 1985-10-01
FI72980C (fi) 1987-08-10
NZ206259A (en) 1986-08-08
CA1239639A (en) 1988-07-26
EP0109253A2 (en) 1984-05-23
JPH0140038B2 (en, 2012) 1989-08-24
PH19293A (en) 1986-03-04
PL250350A1 (en) 1985-04-24
FI834163L (fi) 1984-05-16
IL70228A0 (en) 1984-02-29
AU2130983A (en) 1984-05-24
CS241069B2 (en) 1986-03-13
PL244557A1 (en) 1985-03-26
ES543638A0 (es) 1986-01-16
YU197285A (en) 1986-08-31
IE56234B1 (en) 1991-05-22
NO160262C (no) 1989-03-29
CS845583A2 (en) 1985-07-16
EP0109253B1 (en) 1987-10-14
YU43425B (en) 1989-06-30
PH21560A (en) 1987-12-11
AU544790B2 (en) 1985-06-13
DK518683A (da) 1984-05-16
SU1272996A3 (ru) 1986-11-23
NO834146L (no) 1984-05-16
PL142601B1 (en) 1987-11-30
HUT35273A (en) 1985-06-28
PL143281B1 (en) 1988-01-30
IE832652L (en) 1984-05-15
PT77645B (en) 1986-05-12
EP0109253A3 (en) 1984-09-12
YU224383A (en) 1986-04-30
JPS59104398A (ja) 1984-06-16

Similar Documents

Publication Publication Date Title
ES527249A0 (es) Un procedimiento para la preparacion de 4"-epi-9-desoxo-9a-metil-9a-aza-9a-homoeritromicina a
IT1143917B (it) Composizione antibatterica per l'igiene orale
EP0136830A3 (en) Azahomoerythromycin d derivative and intermediates therefor
MX9203629A (es) Composiciones de anticuerpos monoclonales para el tratamiento profilactico o terapeutico de infecciones bacterianas debidas a estreptococos del grupo b.
MY104109A (en) Antibacterial 9-deoxo-9a-allyl and propargyl-9a-aza-9a-homoerythromycin a derivatives.
ES535624A0 (es) Un procedimiento para la preparacion de 9-deoxo-9a-metil-9a-aza-9a-homoeritromicina b o una sal de la misma
ES505430A0 (es) Procedimiento para la preparacion de 3-0-desmenlistamicina b.
ES551678A0 (es) Un procedimiento para la preparacion de un nuevo compuesto denominado sustancia n. 51262 por cultivo de un microorganismo del genero streptomyces
SE8009049L (sv) 7alfa-metoxicefalosporinderivat, sett for framstellning derav och antibakteriella lekemedel innehallande dessa foreningar
FI853506L (fi) Nya antibioter, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska kompositioner.
DE3169918D1 (en) Cis-c3",c4"-carbonate derivatives of oleandomycin-y, pharmaceutical compositions containing them, and intermediates therefor
DK144284A (da) 2'-desoxyoxanosin, den fremstilling og anvendelse
IT8221854A0 (it) Nuovo composto ad attivita'antibatterica, procedimento per lasua preparazione e relative composizioni farmaceutiche.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20040626